GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.

Lonza said on Thursday it plans to exit the capsules and health ingredients business, as the Swiss contract drugmaker faced a ...

Gland Pharma shares will be in focus after receiving FDA approval for phytonadione injectable emulsion, a product used for ...

Phathom Pharmaceuticals, Inc.'s vonoprazan received multiple approvals, but the stock price showed erratic behavior. Learn ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 22.22% ...

Danish pharma company Bavarian Nordic is shutting down its U.S.-based R&D site in San Diego and laying off all 48 employees ...

The company produces plant-based beverages in Canada and the United States. It could open a new facility in a Midlands county ...

Covetrus announced the expansion of its' site in Arizona, increasing the company’s pharmacy capabilities for producing ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Hepion Pharmaceuticals and Pharma Two B have terminated a reverse merger agreement that was expected to close by the end of ...

Vertex Pharmaceuticals Incorporated looks set for two new drug approvals in early 2025. Click here to read an analysis of ...

We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...